Search for: "Solvay Pharmaceuticals Inc" Results 21 - 40 of 50
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
28 Apr 2011, 3:18 pm by Bexis
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
10 Jun 2010, 10:41 am by FDABlog HPM
  As we previously reported, in that case the district court largely dismissed multidistrict litigation brought by the FTC, direct purchasers, and indirect purchasers challenging certain agreements in which Solvay Pharmaceuticals, Inc. allegedly paid generic drug companies to delay generic competition to Solvay’s drug product ANDROGEL (testosterone gel). [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
II) – This case stems from a February 2009 challenge by the FTC and the California Attorney General concerning  Solvay Pharmaceuticals, Inc. [read post]
7 Dec 2009, 3:57 am by Mara Zimmerman
The relators were former sales representatives at Solvay Pharmaceuticals and alleged that Solvay had established an off-label marketing campaign for a prescription drug used to treat AIDS and cancer patients. [read post]
2 Dec 2009, 11:05 am by dbmadmin
On December 2, 2009, the FTC announced an order settling charges that Watson Pharmaceuticals, Inc. [read post]
24 Nov 2009, 1:11 am by Greg Jones
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
24 Nov 2009, 1:11 am by Greg Jones
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
18 Oct 2009, 5:42 pm
  Judge Brown found that the patent in question, US Patent No. 5,565,473, was valid and enforceable, and [...]...FTC Sues Regarding AndroGel Patent Settlement The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to… [read post]
28 Sep 2009, 1:31 am
Solvay America, Inc., 212 P.3d 614, 632 (Wyo. 2009); Lovick v. [read post]
28 Sep 2009, 1:31 am
Solvay America, Inc., 212 P.3d 614, 632 (Wyo. 2009); Lovick v. [read post]
28 Sep 2009, 1:31 am
Solvay America, Inc., 212 P.3d 614, 632 (Wyo. 2009); Lovick v. [read post]
24 Sep 2009, 5:09 am
Solvay America, Inc., 212 P.3d 614, 632 (Wyo. 2009); Lovick v. [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb)   General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb)… [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
13 Mar 2009, 4:00 am
(Securing Innovation) PriorSmart.com search tool, tracking patent documents (Competitive Info) (Patently-O) Patent damages as an incentive to transact (IP finance) IPscore, new patent evaluation toy (IP finance) Patent portfolios can pull companies out of financial rut (Law360)   Global - Copyright Expanding the public domain: part zero (Creative Commons)     Australia Pioneering decision on non-use: Pioneer Computers Australia Pty Limited v Pioneer KK (Australian Trade… [read post]